Status:
TERMINATED
Masimo Radical-7 Monitor a Useful Adjuvant During Major Spine Surgery
Lead Sponsor:
Cedars-Sinai Medical Center
Collaborating Sponsors:
Masimo Corporation
Conditions:
Major Spine Surgery Procedure
Eligibility:
All Genders
18-80 years
Brief Summary
This is a study designed to compare the agreement of hemoglobin (Hb) measurements, documented at specific time points (the time a blood sample was obtained by the standard clinical care after physicia...
Detailed Description
\*See whether or not the hemoglobin values recorded at the same time matches between the standard clinical practice (CSMC Lab and outside Lab) and the Masimo device
Eligibility Criteria
Inclusion
- Patients scheduled to undergo multiple level spine surgery procedures
- 18 - 80 years of age
- American Society of Anesthesiologists (ASA) Class I - III adults of either sex
- Pregnant women
Exclusion
- Patients with a perfusion index less than 1 or low confidence reading
- Patients with nail polish and /or a nail deformity on a finger that would used for sensor placement
- Patient undergoing cardio-pulmonary bypass
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT01221961
Start Date
October 1 2010
End Date
April 1 2013
Last Update
November 15 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cedars Sinai Medical center
Los Angeles, California, United States, 90048